These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36948587)

  • 1. Randomised controlled trial for the titration of oral corticosteroids using markers of inflammation in severe asthma.
    Ramsahai JM; Simpson JL; Cook A; Gibson PG; McDonald V; Grainge C; Heaney LG; Wark PA
    Thorax; 2023 Sep; 78(9):868-874. PubMed ID: 36948587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Composite type-2 biomarker strategy versus a symptom-risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial.
    Heaney LG; Busby J; Hanratty CE; Djukanovic R; Woodcock A; Walker SM; Hardman TC; Arron JR; Choy DF; Bradding P; Brightling CE; Chaudhuri R; Cowan DC; Mansur AH; Fowler SJ; Niven RM; Howarth PH; Lordan JL; Menzies-Gow A; Harrison TW; Robinson DS; Holweg CTJ; Matthews JG; Pavord ID;
    Lancet Respir Med; 2021 Jan; 9(1):57-68. PubMed ID: 32916135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exhaled nitric oxide levels to guide treatment for children with asthma.
    Petsky HL; Kew KM; Chang AB
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD011439. PubMed ID: 27825189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomised pragmatic trial of corticosteroid optimization in severe asthma using a composite biomarker algorithm to adjust corticosteroid dose versus standard care: study protocol for a randomised trial.
    Hanratty CE; Matthews JG; Arron JR; Choy DF; Pavord ID; Bradding P; Brightling CE; Chaudhuri R; Cowan DC; Djukanovic R; Gallagher N; Fowler SJ; Hardman TC; Harrison T; Holweg CT; Howarth PH; Lordan J; Mansur AH; Menzies-Gow A; Mosesova S; Niven RM; Robinson DS; Shaw DE; Walker S; Woodcock A; Heaney LG;
    Trials; 2018 Jan; 19(1):5. PubMed ID: 29301585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of blood eosinophils and exhaled nitric oxide in adults with mild asthma: a prespecified subgroup analysis of an open-label, parallel-group, randomised controlled trial.
    Pavord ID; Holliday M; Reddel HK; Braithwaite I; Ebmeier S; Hancox RJ; Harrison T; Houghton C; Oldfield K; Papi A; Williams M; Weatherall M; Beasley R;
    Lancet Respir Med; 2020 Jul; 8(7):671-680. PubMed ID: 32171064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reducing asthma attacks in children using exhaled nitric oxide (RAACENO) as a biomarker to inform treatment strategy: a multicentre, parallel, randomised, controlled, phase 3 trial.
    Turner S; Cotton S; Wood J; Bell V; Raja EA; Scott NW; Morgan H; Lawrie L; Emele D; Kennedy C; Scotland G; Fielding S; MacLennan G; Norrie J; Forrest M; Gaillard EA; de Jongste J; Pijnenburg M; Thomas M; Price D
    Lancet Respir Med; 2022 Jun; 10(6):584-592. PubMed ID: 35101183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Breathing for Life Trial: a randomised controlled trial of fractional exhaled nitric oxide (FENO)-based management of asthma during pregnancy and its impact on perinatal outcomes and infant and childhood respiratory health.
    Murphy VE; Jensen ME; Mattes J; Hensley MJ; Giles WB; Peek MJ; Bisits A; Callaway LK; McCaffery K; Barrett HL; Colditz PB; Seeho SK; Attia J; Searles A; Doran C; Powell H; Gibson PG
    BMC Pregnancy Childbirth; 2016 May; 16():111. PubMed ID: 27189595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inflammatory profile of exacerbations in patients with severe refractory eosinophilic asthma receiving mepolizumab (the MEX study): a prospective observational study.
    McDowell PJ; Diver S; Yang F; Borg C; Busby J; Brown V; Shrimanker R; Cox C; Brightling CE; Chaudhuri R; Pavord ID; Heaney LG;
    Lancet Respir Med; 2021 Oct; 9(10):1174-1184. PubMed ID: 33971168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tailored interventions based on exhaled nitric oxide versus clinical symptoms for asthma in children and adults.
    Petsky HL; Cates CJ; Li A; Kynaston JA; Turner C; Chang AB
    Cochrane Database Syst Rev; 2009 Oct; (4):CD006340. PubMed ID: 19821360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interventions for managing asthma in pregnancy.
    Bain E; Pierides KL; Clifton VL; Hodyl NA; Stark MJ; Crowther CA; Middleton P
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD010660. PubMed ID: 25331331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-interleukin-13 and anti-interleukin-4 agents versus placebo, anti-interleukin-5 or anti-immunoglobulin-E agents, for people with asthma.
    Gallagher A; Edwards M; Nair P; Drew S; Vyas A; Sharma R; Marsden PA; Wang R; Evans DJ
    Cochrane Database Syst Rev; 2021 Oct; 10(10):CD012929. PubMed ID: 34664263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of digital measurement of medication adherence and lung function to guide the management of uncontrolled asthma (INCA Sun): a multicentre, single-blinded, randomised clinical trial.
    Hale EM; Greene G; Mulvey C; Mokoka MC; van Boven JFM; Cushen B; Sulaiman I; Brennan V; Lombard L; Walsh J; Plunkett S; McCartan TA; Kerr PJ; Reilly RB; Hughes C; Kent BD; Jackson DJ; Butler M; Counihan I; Hayes J; Faul J; Kelly M; Convery R; Nanzer AM; Fitzgerald JM; Murphy DM; Heaney LG; Costello RW;
    Lancet Respir Med; 2023 Jul; 11(7):591-601. PubMed ID: 36963417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omalizumab for asthma in adults and children.
    Normansell R; Walker S; Milan SJ; Walters EH; Nair P
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD003559. PubMed ID: 24414989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adults.
    Petsky HL; Li A; Chang AB
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD005603. PubMed ID: 28837221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic review and meta-analysis: tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils).
    Petsky HL; Cates CJ; Lasserson TJ; Li AM; Turner C; Kynaston JA; Chang AB
    Thorax; 2012 Mar; 67(3):199-208. PubMed ID: 20937641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exhaled nitric oxide levels to guide treatment for adults with asthma.
    Petsky HL; Kew KM; Turner C; Chang AB
    Cochrane Database Syst Rev; 2016 Sep; 9(9):CD011440. PubMed ID: 27580628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial.
    Lee LA; Bailes Z; Barnes N; Boulet LP; Edwards D; Fowler A; Hanania NA; Kerstjens HAM; Kerwin E; Nathan R; Oppenheimer J; Papi A; Pascoe S; Brusselle G; Peachey G; Sule N; Tabberer M; Pavord ID
    Lancet Respir Med; 2021 Jan; 9(1):69-84. PubMed ID: 32918892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood eosinophil count and FeNO to predict benralizumab effectiveness in real-life severe asthma patients.
    Watanabe H; Shirai T; Hirai K; Akamatsu T; Nakayasu H; Tamura K; Masuda T; Takahashi S; Tanaka Y; Kishimoto Y; Oishi K; Saigusa M; Yamamoto A; Morita S; Asada K
    J Asthma; 2022 Sep; 59(9):1796-1804. PubMed ID: 34348060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managing Asthma in Pregnancy (MAP) trial: FENO levels and childhood asthma.
    Morten M; Collison A; Murphy VE; Barker D; Oldmeadow C; Attia J; Meredith J; Powell H; Robinson PD; Sly PD; Gibson PG; Mattes J
    J Allergy Clin Immunol; 2018 Dec; 142(6):1765-1772.e4. PubMed ID: 29524536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exhaled nitric oxide monitoring does not reduce exacerbation frequency or inhaled corticosteroid dose in paediatric asthma: a randomised controlled trial.
    Pike K; Selby A; Price S; Warner J; Connett G; Legg J; Lucas JS; Peters S; Buckley H; Magier K; Foote K; Drew K; Morris R; Lancaster N; Roberts G
    Clin Respir J; 2013 Apr; 7(2):204-13. PubMed ID: 22747899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.